627 related articles for article (PubMed ID: 22155911)
41. [Analysis of mutations in DNA polymerase and thymidine kinase genes of herpes simplex virus clinical isolates resistant to antiherpetic drugs].
Korovina AN; Gus'kova AA; Skoblov MIu; Andronova VL; Galegov GA; Kochetkov SN; Kukhanova MK; Skoblov IuS
Mol Biol (Mosk); 2010; 44(3):488-96. PubMed ID: 20608173
[TBL] [Abstract][Full Text] [Related]
42. Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients.
Morfin F; Souillet G; Bilger K; Ooka T; Aymard M; Thouvenot D
J Infect Dis; 2000 Jul; 182(1):290-3. PubMed ID: 10882609
[TBL] [Abstract][Full Text] [Related]
43. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
44. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.
Suzutani T; Ishioka K; De Clercq E; Ishibashi K; Kaneko H; Kira T; Hashimoto K; Ogasawara M; Ohtani K; Wakamiya N; Saijo M
Antimicrob Agents Chemother; 2003 May; 47(5):1707-13. PubMed ID: 12709344
[TBL] [Abstract][Full Text] [Related]
45. Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.
Blot N; Schneider P; Young P; Janvresse C; Dehesdin D; Tron P; Vannier JP
Bone Marrow Transplant; 2000 Oct; 26(8):903-5. PubMed ID: 11081393
[TBL] [Abstract][Full Text] [Related]
46. Novel mutations in antiviral multiresistant HSV-2 genital lesion: A case report.
Khellaf L; Bouscarat F; Burrel S; Fidouh N; Hachon L; Bucau M; Lariven S; Boutolleau D; Joly V; Ghosn J; Le Pluart D; Thy M
J Med Virol; 2022 Dec; 94(12):6122-6126. PubMed ID: 35973907
[TBL] [Abstract][Full Text] [Related]
47. Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa.
Muller EE; Maseko DV; Kularatne RS
Antiviral Res; 2022 Apr; 200():105277. PubMed ID: 35271913
[TBL] [Abstract][Full Text] [Related]
48. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
[TBL] [Abstract][Full Text] [Related]
49. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M
J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848
[TBL] [Abstract][Full Text] [Related]
50. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
51. Resistance of herpes simplex virus type 1 to acyclovir: thymidine kinase gene mutagenesis study.
Frobert E; Ooka T; Cortay JC; Lina B; Thouvenot D; Morfin F
Antiviral Res; 2007 Feb; 73(2):147-50. PubMed ID: 16970995
[TBL] [Abstract][Full Text] [Related]
52. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
53. Long-term observation of herpes simplex virus type 1 (HSV-1) infection in a child with Wiskott-Aldrich syndrome and a possible reactivation mechanism for thymidine kinase-negative HSV-1 in humans.
Shiota T; Kurane I; Morikawa S; Saijo M
Jpn J Infect Dis; 2011; 64(2):121-6. PubMed ID: 21519125
[TBL] [Abstract][Full Text] [Related]
54. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
[TBL] [Abstract][Full Text] [Related]
55. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
[TBL] [Abstract][Full Text] [Related]
56. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.
Wang LX; Takayama-Ito M; Kinoshita-Yamaguchi H; Kakiuchi S; Suzutani T; Nakamichi K; Lim CK; Kurane I; Saijo M
Jpn J Infect Dis; 2013; 66(5):404-10. PubMed ID: 24047739
[TBL] [Abstract][Full Text] [Related]
57. Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.
Ikawa Y; Fujiki T; Nishimura R; Noguchi K; Koshino E; Fujiki A; Fukuda M; Kuroda R; Mase S; Araki R; Maeba H; Shiraki K; Yachie A
J Infect Chemother; 2019 Jan; 25(1):65-67. PubMed ID: 30064949
[TBL] [Abstract][Full Text] [Related]
58. Antiviral susceptibility of recombinant Herpes simplex virus 1 strains with specific polymerase amino acid changes.
Rose R; Brunnemann AK; Baukmann S; Bühler S; Fickenscher H; Sauerbrei A; Zell R; Krumbholz A
Antiviral Res; 2021 Nov; 195():105166. PubMed ID: 34419483
[TBL] [Abstract][Full Text] [Related]
59. Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.
Wang K; Mahalingam G; Hoover SE; Mont EK; Holland SM; Cohen JI; Straus SE
J Virol; 2007 Jul; 81(13):6817-26. PubMed ID: 17459924
[TBL] [Abstract][Full Text] [Related]
60. Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor.
Burrel S; Aït-Arkoub Z; Agut H; Boutolleau D
Antiviral Res; 2012 Jan; 93(1):199-203. PubMed ID: 22061617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
